These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11037883)

  • 1. Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of the type I collagen gene.
    Ihn H; Tamaki K
    Arthritis Rheum; 2000 Oct; 43(10):2240-7. PubMed ID: 11037883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
    Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H; Yamane K; Kubo M; Tamaki K
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.
    Saitta B; Gaidarova S; Cicchillitti L; Jimenez SA
    Arthritis Rheum; 2000 Oct; 43(10):2219-29. PubMed ID: 11037881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.
    Hitraya EG; Varga J; Artlett CM; Jiménez SA
    Arthritis Rheum; 1998 Nov; 41(11):2048-58. PubMed ID: 9811061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the immunosuppressant FK-506 on human alpha2(I) collagen gene expression and transforming growth factor beta signaling in normal and scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Apr; 52(4):1237-47. PubMed ID: 15818662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
    Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
    Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    Arthritis Rheum; 2005 Sep; 52(9):2897-905. PubMed ID: 16142753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
    Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
    Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
    Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
    Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.
    Heegaard AM; Xie Z; Young MF; Nielsen KL
    J Cell Biochem; 2004 Oct; 93(3):463-75. PubMed ID: 15372625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential regulatory elements of the constitutive up-regulated alpha2(I) collagen gene in scleroderma dermal fibroblasts.
    Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
    Biochem Biophys Res Commun; 2006 May; 343(3):904-9. PubMed ID: 16564026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways.
    Distler JH; Hagen C; Hirth A; Müller-Ladner U; Lorenz HM; del Rosso A; Michel BA; Gay RE; Nanagara R; Nishioka K; Matucci-Cerinic M; Kalden JR; Gay S; Distler O
    Mol Pharmacol; 2004 Feb; 65(2):389-99. PubMed ID: 14742681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin.
    Louneva N; Huaman G; Fertala J; Jiménez SA
    Arthritis Rheum; 2006 Apr; 54(4):1298-308. PubMed ID: 16575855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
    Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
    J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced binding of Sp1/Sp3 transcription factors mediates the hyperoxia-induced increased expression of the lung type I cell gene T1alpha.
    Cao YX; Ramirez MI; Williams MC
    J Cell Biochem; 2003 Aug; 89(5):887-901. PubMed ID: 12874823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.